Article thumbnail

Congenital Cytomegalovirus Mortality in the United States, 1990–2006

By Benjamin N. Bristow, Kaitlin A. O'Keefe, Shira C. Shafir and Frank J. Sorvillo


Cytomegalovirus (CMV) is a member of the herpes family of viruses, which is transmitted by sexual and non-sexual contact. Human CMV causes a wide variety of infection and illness in healthy adults, in those with compromised immune systems (such as AIDS), in those with cardiovascular disease, and in pregnant women who can pass the infection to their unborn child (congenital CMV). Treatment options for congenital CMV are limited and no effective vaccine to protect against CMV currently exists. Previous studies have demonstrated that African Americans and Mexican Americans are at an increased risk for congenital CMV infections. In this study, the authors examined death certificate data of US Residents from 1990–2006 in which congenital CMV was listed as one of the diagnoses at death. The analysis demonstrated that there is a significant burden of congenital CMV deaths in infants (<1 year old) with African Americans and Native Americans overrepresented. This study helps quantify congenital CMV deaths among US residents and adds further support to the importance of funding CMV vaccine research

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2006). A comparison of underlying cause and multiple causes of death:
  2. (1998). Age standardization of death rates: implementation of the year
  3. (2010). Census regions and divisions of the United States. http://
  4. (2008). Changing trends in hepatitis C-related mortality in the United States,
  5. (1996). Congenital cytomegalovirus infection in infants infected with human immunodeficiency virus type 1. Pediatr Infectious Dis
  6. (2002). Congenital cytomegalovirus infection: Review of the epidemiology and outcome.
  7. (2005). Congenital cytomegalovirus screening.
  8. (1991). Cytomegalovirus and child day care: risk factors for maternal infection.
  9. (2005). Death certification errors at an academic institution.
  10. (2007). Deaths from cysticercosis, United States.
  11. (2008). Decreasing listeriosis mortality in the United States,
  12. (1985). Epidemiology of cytomegaloviral infection in a hetergenous population of pregnant women.
  13. (2006). Fetal effects of primary and secondary cytomegalovirus infection in pregnancy.
  14. (2010). for Health Statistics. 1990–2006, mortality data, multiple causeof-death public-use data files. Available at: elec_prods/subject/mortmcd.htm.
  15. (2006). for Health Statistics. Estimates of the July 1, 2000–July 1, 2006, United States resident population from the Vintage
  16. (2009). Guidelines on CMV congenital infection.
  17. (2007). Incidence of cytomegalovirus infection among the general population and pregnant women in the United States.
  18. (2001). Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.
  19. (1993). Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations,
  20. (2010). Maternal human immunodeficiency virus infection and congenital transmission of cytomegalovirus.
  21. Medicine (U.S.) Committee to Study Priorities for Vaccine Development. Vaccines for the 21st Century: A Tool for Decision making (2000) Washington D.C.,
  22. (2004). National Vaccine Advisory Committee
  23. (2009). Neglected diseases amid wealth in the United States and Europe.
  24. (2008). Neglected infections of poverty in the United States of America.
  25. (2007). Persistent socioeconomic disparities in infant, neonatal, and postneonatal mortality rates in the United States,
  26. (2004). Prevention of child-tomother transmission of cytomegalovirus among pregnant women.
  27. (1986). Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome.
  28. (2005). Progress in cytomegalovirus vaccine development.
  29. (2007). Recent advances in the prevention and treatment of congenital cytomegalovirus infections.
  30. (2007). Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection.
  31. (2006). Risk factors for congenital cytomegalovirus infection in the offspring of young women: Exposure to young children and recent onset of sexual activity.
  32. (1991). Sexually transmitted diseases in mothers of neonates with congenital cytomegalovirus infection.
  33. (1999). Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus.
  34. (1992). Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality.
  35. (2009). The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data.
  36. (2006). The epidemiology and prevention of congenital cytomegalovirus infection and disease: Activities of the Centers for Disease Control and Prevention Workgroup.
  37. (2007). Using multiple-cause-of-death data to investigate associations and causality between conditions listed on the death certificate.
  38. (2005). Washing our hands of the congenital cytomegalovirus disease epidemic.
  39. (2007). Widening socioeconomic disparities in US childhood mortality,